- 2016: NIH FOIA office withholds all records related to exclusive license on HER2+ breast cancer treatment technology
- WHO CEWG 2016: Statement of Health Action International, Knowledge Ecology International and STOPAIDS
- Rep. Lloyd Doggett keynote address at CAP drug pricing event highlights Xtandi, federal funding of pharmaceutical R&D
- China: as PCT patent filings increase, GDP growth has decreased
- Biolyse Pharma offers to supply enzalutamide (Xtandi) for $3 per pill to Medicare and developing countries
- KEI comment on USTR's 2016 Special 301 report
- Transparency of patents on medicines and other technologies
- WHO releases program of work and progress report in advance of Consultative Expert Working Group on R&D (2-4 May 2016)
- 2015 Oct 16 version: RCEP draft text for investment chapter
- Letter to HHS and NIH regarding impact of high prices on cost effectiveness of Xtandi
During today's discussion at the WIPO Standing Committee on the Law of Patents (SCP) on patent quality KEI make four points in its intervention.
1. WIPO should consider gathering information on the costs of litigation to challenge the validity of patents.
2. WIPO should consider creating a database to share information on the cases where litigation has resulted findings that patent claims as invalid.
The World Intellectual Property Organization (WIPO) has convened the 16th session of the WIPO Standing Committee on the Law of Patents (SCP). The SCP elected Albert Tramposch, Administrator for Policy and External Affairs, USPTO as Chair.
Knowledge Ecology International: Patents and Health
DATE: Tuesday, 17 May 2011
VENUE: Room B at the WIPO Main Building
AIDS Drug Assistance Programs (ADAP) are state run programs that provide medicines to low-income HIV-positive patients who either have limited or no insurance coverage. ADAPs are essential in providing life-saving medicines to low-income patients, but these programs are threatened by the high costs of treatment.
On April 19, 2011, Dr Kumariah Balasubramaniam died at his home in Sri Lanka. Dr. Balasubramaniam, known to many as Dr. Bala, was described by Professor Colvin Gooneratne as "one of the most knowledgeable, resolute, articulate, versatile, resilient and in many other ways exceptionally brilliant health activists [the world] has produced." My tribute to Dr. Bala is in the Huffington Post. Prof.
IIPI side event at WIPO to present on a joint USPTO/IIPI project on "Missed Opportunities Patenting in Developing Countries"Submitted by thiru on 5. May 2011 - 5:04
The International Intellectual Property Institute (IIPI) is holding a side event at WIPO today on the margins of the WIPO Committee on Development and Intellectual Property (CDIP) on "Missed Opportunities for Patenting in Developing Countries" and "Innovation Opportunities in the Philippines".
The program flyer for the event notes that this initiative is a "joint project between the Intellectual Property Institute (IIPI) and the U.S. Patent and Trademark Office (USPTO)."
On 11 March 2011, Dr. Margaret Chan, Director-General of the World Health Organization (WHO), convened an "informal advisory meeting" to review different approaches to "securing greater coherence in global health" and to further WHO's core function of "the directing and coordinating authority on international health work". A summary report of this informal advisory meeting and the WHO's background paper on "Global Health Governance and the WHO" can be found here: http://keionline.org/sites/default/files/WHOglobalhealthgovernancedraft.pdf
On April 26, 2011, Senator Wyden released a redacted version of the Congressional Research Service (CRS) report on ACTA that has been the subject to an ongoing Freedom of Information ACT (FOIA) dispute with USTR.
This is a link to the report that USTR claimed they could not release because of restrictions on its use by Senator Wyden.
In a somewhat unexpected and encouraging ruling, on April 12, 2011, the District Court for the District of Columbia rejected USTR claims that the release of certain documents relating to a trade negotiations can be shielded from the FOIA.
The case involves a FOIA dispute between the Center for International Environmental Law (CIEL) and the the United States Trade Representative's (USTR) over documents revealing the US negotiating position on the Investment Chapter in the proposed Free Trade Agreement of the Americas (FTAA).
Confirmation that Obama Administration was "lone hold out" for releasing bracketed ACTA text to the public in Summer of 2010.Submitted by KEI Staff on 25. April 2011 - 15:49
On July 1, 2010, William Yue, the Senior Counsel, Office of the Chief Counsel for International Commerce at the US Department of Commerce, wrote to Joel Blank and John Cobau about the ACTA negotiations. John Cobau was the Chief Counsel for International Commerce at the U.S. Department of Commerce, and Joel Blank was International Attorney-Advisor at US Department of Commerce.
A redacted version of this email was the only document released to KEI as part of a larger FOIA request concerning the Department of Commerce role in the ACTA negotiations. A copy is available here:
Ambassador Kirk's responses to Senate Finance Committee suggests enforcement of TRIPS-plus data exclusivity measuresSubmitted by Krista Cox on 25. April 2011 - 9:41
Recently, Ambassador Ron Kirk, the United States Trade Representative (USTR) responded to follow up questions from the U.S. Senate Finance Committee regarding the 2011 Trade Agenda. In addition to asserting that the U.S. Congress is not bound by ACTA, the responses suggest USTR desire to establish requirements for the implementation of data exclusivity provisions.
Six NGOs, including Knowledge Ecology International (KEI), Medecins Sans Frontieres (MSF), Oxfam, Third World Network (TWN), Universities Allied for Essential Medicines (UAEM), and Young Professionals Chronic Disease Network (YP-CDN), recently submitted recommendations to Member States to control non-communicable diseases (NCDs) in low- and middle-income countries in advance of the Moscow Ministerial conference.
A PDF of the joint statement with logos of the groups is available here:
On August 7, 2008, Stewart Baker, the Assistant Secretary for Policy at the Department of Homeland Security, sent a one page letter and a three page "Policy Position on Border Measures of the Anti-Counterfeiting Trade Agreement."
Stewart Baker was the General Counsel of the National Security Agency from 1992 to 1994, and was appointed the first Assistant Secretary for Policy at the Department of Homeland Security (DHS) by George W Bush.
KEI just received the attached letter from the Executive Office of the President's Office of the United States Trade Representative (USTR) rejecting our appeal of USTRs decision to withhold a study by the Library of Congress' Congressional Research Service on ACTA that was done for Senator Wyden.